FIELD: organic synthesis.
SUBSTANCE: 1-oxo-3-(1H-indol-3-yl)-1,2,3,4-tetrahydroisoquinolines (including their cis- and trans-isomers) are depicted by following general formulae: (1) and (2), in which R1, R2, and R4 independently represent cyclic system substituents selected from hydrogen atom and alkyl; R3 is amino group selected from alkyl, cycloalkyl, and alkyl optionally substituted by aryl, heteroaryl, heterocyclyl, alkoxy, amino, alkylamino, and dialkylamino; R5 and R6 independently represent amino group substituents selected from hydrogen, aryl, heteroaryl, heterocyclyl, cycloalkyl, alkyl, and alkyl optionally substituted by aryl, heteroaryl, heterocyclyl, cycloalkyl, cycloalkenyl, alkoxy, amino, alkylamino, dialkylamino, or arylalkylamino; or R5 and R6, together with nitrogen atom to which they are linked, form optionally substituted aza-heterocycle. Method of preparing compounds 1 consists in reaction of corresponding indol-3-ylmethylamines with homophthalic anhydrides in an organic solvent. Compounds 2 are prepared by treating compounds 1 with thionyl chloride or 1,1'-carbonyldiimidazole to form corresponding derivatives, which are reacted with corresponding amines in an organic solvent. Compounds of invention exhibit proteinkinase inhibiting activities. Combinatory and focused libraries are also provided to reveal leading compounds.
EFFECT: expanded synthetic possibilities in quinoline series and increased choice of proteinkinase inhibitors.
3 cl, 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF NOSCAPINE (VARIANTS), COMBINATORY AND FOCUSED LIBRARIES, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PREPARING (VARIANTS) AND USING | 2006 |
|
RU2304584C1 |
SUBSTITUTED (R)-3-(4-METHYLCARBAMOYL-3-FLUOROPHENYLAMINO)-TETRAHYDRO-FURAN-3-ENE CARBOXYLIC ACIDS AND ESTERS THEREOF, METHOD FOR PRODUCTION AND USE THEREOF | 2013 |
|
RU2520134C1 |
LIGANDS OF 5-HT RECEPTORS, PHARMACEUTICAL FORMULATION, PRODUCTION METHOD AND MEDICAL PRODUCT | 2006 |
|
RU2329044C1 |
PHARMACEUTICAL COMPOSITION, METHOD FOR ITS PREPARING AND USING | 2006 |
|
RU2303597C1 |
ANELLATED CABAMOYLAZAHETEROCYCLES, FOCUSED LIBRARY, PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING | 2005 |
|
RU2281947C1 |
SUBSTITUTED 2-AMINO-3-SULFONYL-TETRAHYDRO-PYRAZOLO[1,5-a]PYRIDO-PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT RECEPTORS, METHODS OF PRODUCING AND USING SAID COMPOUNDS | 2008 |
|
RU2384581C2 |
TETRAHYDRO-PYRAZOLO[1,5-a]PYRIDO-PYRIMIDINES - SEROTONIN 5-HT RECEPTOR ANTAGONISTS, METHODS OF PRODUCING AND USING SAID COMPOUNDS | 2008 |
|
RU2391343C1 |
SUBSTITUTED [1,2,4]TRIAZOLO[4,3-a]PYRIDINES, DEMONSTRATING PROPERTIES OF ANTAGONISTS OF ADENOSINE A2A RECEPTORS, AND THEIR APPLICATION | 2013 |
|
RU2534804C1 |
SUBSTITUTED 4-{[4-(3,3-DIOXIDO-1,3-BENZOXATHIOL-6-YL)ARYLOXY]METHYL}PIPERIDINES AS GPR119 RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR PRODUCING AND USING THEM | 2014 |
|
RU2576037C1 |
METHOD OF OBTAINING DISPIROINDOLINONES | 2018 |
|
RU2682678C1 |
Authors
Dates
2007-07-10—Published
2006-03-14—Filed